Search bioRxiv⌕ Search

Biology subjects

Xu, A. E.

Publications and source records attributed to Xu, A. E..

2 recordsLinked to original sources

The cytosolic cysteinyl-tRNA synthetase is capable of regulating ATF4 translation independent of eIF2α phosphorylation state

In mammalian cells, the integrated stress response (ISR) triggers ATF4 translation under general conditions of cell stress. Mammalian target of rapamycin (mTOR) signaling also triggers ATF4 translation under general pro-growth conditions. While the transcriptomic changes of these two contradictory pathways are have been studied, a full understanding of all pathways capable of increasing ATF4 translation and how these pathways are regulated and interact with each other remains unknown. In a genome-wide CRISPRi screen, we found that loss of CARS is sufficient to activate ATF4 translation independent of canonical ISR signaling. This ATF4 translation does not require eIF2 phosphorylation and does not require MTOR kinase activity. In a genome-wide epistasis CRISPRi screen using a staggered sgRNA infection strategy, we identified METAP2 and OGT as potential downstream factors in this pathway. This represents a novel pathway for activation of ATF4 translation that may enable targeted manipulation of ATF4 for beneficial therapeutic outcomes.

molecular biology↗

Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy

1Antibodies can play an important role in innate and adaptive immune responses against cancer, and in preventing infectious disease. Flow cytometry analysis of sera of immune mice that were previously cured of their melanoma through a combined immunotherapy regimen with long-term memory showed strong antibody-binding against melanoma tumor cell lines. Using a high-density whole-proteome peptide array, we assessed potential protein-targets for antibodies found in immune sera. Sera from 6 of these cured mice were analyzed with this high-density, whole-proteome peptide array to determine specific antibody-binding sites and their linear peptide sequence. We identified thousands of peptides that were targeted by 2 or more of these 6 mice and exhibited strong antibody binding only by immune, not naive sera. Confirmatory studies were done to validate these results using 2 separate ELISA-based systems. To the best of our knowledge, this is the first study of the "immunome" of protein-based epitopes that are recognized by immune sera from mice cured of cancer via immunotherapy. summaryHoefges et al. utilized a whole-proteome peptide array approach to show that C57BL/6 mice develop a large repertoire of antibodies against linear peptide sequences of their melanoma after receiving a curative immunotherapy regimen consisting of radiation and an immunocytokine.

immunology↗